Changes of serum cytokines after the long term immunotherapy with Japanese hop pollen extracts
- PMID: 17043410
- PMCID: PMC2721987
- DOI: 10.3346/jkms.2006.21.5.805
Changes of serum cytokines after the long term immunotherapy with Japanese hop pollen extracts
Abstract
Japanese hop (Hop J) pollen has been considered as one of the major causative pollen allergens in the autumn season. We developed a new Hop J immunotherapy extract in collaboration with Allergopharma (Reinbeck, Germany) and investigated immunologic mechanisms during 3 yr immunotherapy. Twenty patients (13 asthma with rhinitis and 7 hay fever) were enrolled from Ajou University Hospital. Sera were collected before, 1 yr, and 3 yr after the immunotherapy. Changes of serum specific IgE, IgG1, and IgG4 levels to Hop J pollen extracts and serum IL-10, IL-12, TGF-beta1 and soluble CD23 levels were monitored by ELISA. Skin reactivity and airway hyper-responsiveness to methacholine were improved during the study period. Specific IgG1 increased at 1 yr then decreased again at 3 yr, and specific IgG4 levels increased progressively (p<0.05, respectively), whereas total and specific IgE levels showed variable responses with no statistical significance. IL-10, TGF-beta1 and soluble CD23 level began to decrease during first year and then further decreased during next two years with statistical significances. (p<0.05, respectively). In conclusion, these findings suggested the favorable effect of long term immunotherapy with Hop J pollen extracts can be explained by lowered IgE affinity and generation of specific IgG4, which may be mediated by IL-10 and TGF-beta1.
Figures





Similar articles
-
Clinical and immunologic changes after allergen immunotherapy with Hop Japanese pollen.Ann Allergy Asthma Immunol. 2001 Apr;86(4):444-8. doi: 10.1016/S1081-1206(10)62493-3. Ann Allergy Asthma Immunol. 2001. PMID: 11345290 Clinical Trial.
-
The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.Pediatr Allergy Immunol. 2006 Sep;17(6):396-407. doi: 10.1111/j.1399-3038.2006.00442.x. Pediatr Allergy Immunol. 2006. PMID: 16925684 Clinical Trial.
-
Evidence of Hop Japanese pollinosis in Korea: IgE sensitization and identification of allergenic components.J Allergy Clin Immunol. 1997 Oct;100(4):475-9. doi: 10.1016/s0091-6749(97)70138-6. J Allergy Clin Immunol. 1997. PMID: 9338540
-
Immunotherapy in pollen and mould asthma.Monaldi Arch Chest Dis. 1994 Apr;49(2):150-3. Monaldi Arch Chest Dis. 1994. PMID: 8049700 Review.
-
Emerging Hop Japanese Pollinosis in Asia.Curr Protein Pept Sci. 2022;23(11):714-720. doi: 10.2174/1389203723666220603155320. Curr Protein Pept Sci. 2022. PMID: 35658882 Review.
Cited by
-
Current immunological approaches for management of allergic rhinitis and bronchial asthma.Inflamm Res. 2009 Sep;58(9):523-36. doi: 10.1007/s00011-009-0033-7. Epub 2009 Mar 31. Inflamm Res. 2009. PMID: 19333724 Review.
References
-
- Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic disease. J Allergy Clin Immunol. 1998;102:558–562. - PubMed
-
- Norman PS. Immunotherapy: 1999-2004. J Allergy Clin Immunol. 2004;113:1013–1023. - PubMed
-
- Jutel M, Akdis M, Budak F, Casaulta CA, Wrzyszcz M, Blaser K, Akdis CA. IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol. 2003;33:1205–1214. - PubMed
-
- Nouri-Aria KT, Wachholz PA, Francis JN, Jacobson MR, Walker SM, Wilcock LK, Staple SQ, Aalberse RC, Till SJ, Durham SR. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol. 2004;172:3252–3259. - PubMed
-
- Park HS, Nahm DH, Suh CH, Lee SM, Choi SY, Jung KS, Lee SY, Park K. Evidence of Hop Japanese pollinosis in Korea: IgE sensitization and identification of allergenic components. J Allergy Clin Immunol. 1997;100:475–479. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources